Fibroblastic and Myofibroblastic Tumors of Children: New Genetic Entities and New Ancillary Testing

F1000Research - United Kingdom
doi 10.12688/f1000research.16236.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd

Related search

Retrospective Histopathologic Evaluation of Fibroblastic Versus Myofibroblastic Entities of the Oral Mucosa

English

Serum Creatinine and Albumin Predict Sarcoma-Specific Survival in Patients With Myofibroblastic and Fibroblastic Sarcomas

Journal of Orthopaedic Research
OrthopedicsSports Medicine
2017English

SAGE Analysis of Pediatric Tumors Identifies New Markers and Common Genetic Pathways

Nature Genetics
Genetics
2001English

Genes in the Basement, Postmortem Genetic Testing…and 3 (New) Realities

Circulation: Cardiovascular Genetics
2017English

Soft Tissue Tumors: Inflammatory Myofibroblastic Tumor

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

The Genetic Testing of Children

1999English

Eosinophilic Kidney Tumors: Old and New

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2019English

PD-L1 Expression in Inflammatory Myofibroblastic Tumors

Modern Pathology
Forensic MedicinePathology
2018English

7. Pathological and Clinical Characteristics of the Proposed New Entities

1983English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy